You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Histone Deacetylase Inhibitors

Showing 26 - 50 of 4,574
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large B Cell Lymphoma Trial (Pembrolizumab and CXD101)

Withdrawn
  • Diffuse Large B Cell Lymphoma
  • Pembrolizumab and CXD101
  • (no location specified)
Aug 12, 2021

Adult T-cell Leukemia/Lymphoma, Extranodal NK-/T-cell Lymphoma, Nasal Type, Enteropathy-Associated T-Cell Lymphoma Trial run by

Not yet recruiting
  • Adult T-cell Leukemia/Lymphoma
  • +4 more
  • CC-486 (5-azacitidine)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Renal Cell Carcinoma Trial in United States (LBH589)

Completed
Has Results
  • Renal Cell Carcinoma
  • Fort Myers, Florida
  • +9 more
Oct 26, 2021

Recurrent Chronic Lymphoid Leukemia Trial in Boston (ACY-1215, Ibrutinib, Idelalisib)

Active, not recruiting
  • Recurrent Chronic Lymphoid Leukemia
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 19, 2022

Angioimmunoblastic T-cell Lymphoma Trial in Guangzhou (Sintilimab, Chidamide)

Not yet recruiting
  • Angioimmunoblastic T-cell Lymphoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 2, 2021

Safety and Efficacy Trial in Suzhou (Chidamide)

Recruiting
  • Safety and Efficacy
  • Suzhou, Jiangsu, China
    First Affiliated Hospital,Soochow University
Nov 30, 2021

Chronic Infection, HIV Trial in Sao Paulo (Maraviroc, Dolutegravir, Dendritic Cell Vaccine)

Completed
  • Chronic Infection
  • HIV
  • Sao Paulo, SP, Brazil
    CCDI
Jul 25, 2020

Leiomyosarcoma, Endometrial Stromal Tumors, Carcinosarcomas Uterine Trial in Graz (Vorinostat Oral Capsule)

Terminated
Has Results
  • Leiomyosarcoma
  • +2 more
  • Vorinostat Oral Capsule
  • Graz, Austria
    Medical University of Graz, Clinic of Obstetrics and Gynecology
Jul 27, 2020

HIV Trial in Melbourne (Disulfiram, (National Drug Code) NDC 0378-4141-01, Vorinostat, NDC 00006-0568-40)

Terminated
  • HIV Infections
  • Disulfiram, (National Drug Code) NDC 0378-4141-01
  • Vorinostat, NDC 00006-0568-40
  • Melbourne, Victoria, Australia
    Department of Infectious Diseases, Alfred Hospital
Oct 27, 2021

HIV-1-infection Trial in Rotterdam (Valproic Acid, Pyrimethamine)

Completed
  • HIV-1-infection
  • Rotterdam, Netherlands
    Erasmus MC
Apr 28, 2021

APL Trial in Shanghai (Chidamide+venetoclax)

Active, not recruiting
  • APL
  • Shanghai, Shanghai, China
    Jiong HU
May 30, 2023

Recurrent Plasma Cell Myeloma Trial in Columbus (Dexamethasone, HDAC Inhibitor AR-42, Laboratory Biomarker Analysis)

Completed
  • Recurrent Plasma Cell Myeloma
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jun 10, 2021

Multiple Myeloma Trial in Hackensack (Vorinostat, Lenalidomide, Carfilzomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Vorinostat, Lenalidomide, Carfilzomib, Dexamethasone
  • Hackensack, New Jersey
    Hackensack University Medical Center
Oct 4, 2021

Extensive Stage Lung Small Cell Carcinoma, Malignant Solid Tumor, Metastatic Malignant Tumor in the Brain Trial in United States

Active, not recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +2 more
  • Atezolizumab
  • +3 more
  • New York, New York
  • +4 more
Jul 16, 2022

Active Systemic, Onset Juvenile Idiopathic Arthritis Trial in Bucharest, Niš, Belgrade (ITF2357)

Completed
Has Results
  • Active Systemic
  • Onset Juvenile Idiopathic Arthritis
  • Bucharest, Romania
  • +4 more
Apr 8, 2021

Leukemia, Leukemia, Acute, Leukemia, Lymphoblastic Trial in Guangzhou (Chidamide, Dasatinib)

Recruiting
  • Leukemia
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Hematology, Nanfang Hospital
Jun 28, 2022

Esophageal Squamous Cell Carcinoma, Intestinal Flora Trial in Suzhou (SintilimabCombined With Chemotherapy)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Intestinal Flora
  • SintilimabCombined With Chemotherapy
  • Suzhou, Jiangsu, China
    The first affiliated hospital of soochow university
Jan 5, 2022

Osteosarcoma Trial (Tucidinostat, Apatinib)

Not yet recruiting
  • Osteosarcoma
  • Tucidinostat, Apatinib
  • (no location specified)
Nov 5, 2023

Neuroendocrine Tumors, Neuroendocrine Tumor Grade 3, Neuroendocrine Carcinoma Trial in Xiamen, Harbin (Chidamide, Sintilimab)

Recruiting
  • Neuroendocrine Tumors
  • +3 more
  • Xiamen, Fujian, China
  • +1 more
Nov 22, 2021

Lymphoid Malignancies, Lymphoma, Hodgkin Lymphoma Trial in New York (Romidepsin, Oral 5-Azacitidine)

Terminated
  • Lymphoid Malignancies
  • +3 more
  • New York, New York
    Columbia University Medical Center
Jan 5, 2021

HIV/AIDS Trial in Guangzhou (Chidamide with CAR-T or TCR-T cell therapy)

Completed
  • HIV/AIDS
  • Chidamide with CAR-T or TCR-T cell therapy
  • Guangzhou, Guangdong, China
    Guangzhou 8th People's Hospital
Jul 19, 2021

Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Beijing, Xiamen, Harbin (Chidamide, Etoposide + Cisplatin/Carboplatin)

Recruiting
  • Neuroendocrine Tumors
  • Neuroendocrine Carcinoma
  • Beijing, Beijing, China
  • +2 more
Nov 2, 2021

Brain Stem Tumor, Pineal Region Tumor, Recurrent Lymphoma Trial in United States (Entinostat, Laboratory Biomarker Analysis,

Completed
Has Results
  • Brain Stem Neoplasm
  • +9 more
  • Birmingham, Alabama
  • +20 more
Jan 6, 2023

Hematological Malignancies, Multiple Myeloma, Hodgkin's Lymphoma Trial in Worldwide (Tinostamustine)

Recruiting
  • Hematological Malignancies
  • +3 more
  • Phoenix, Arizona
  • +19 more
Apr 12, 2022

HPV-Related Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx Trial in

Not yet recruiting
  • HPV-Related Squamous Cell Carcinoma
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 31, 2023